X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28) 28
humans (20) 20
microbiology (19) 19
virology (17) 17
virus diseases (16) 16
viruses (14) 14
infections (13) 13
hcv (12) 12
hepatitis (10) 10
biochemical phenomena, metabolism, and nutrition (9) 9
hepatitis c virus (9) 9
hepacivirus - genetics (8) 8
research article (8) 8
antiviral agents (7) 7
biology (7) 7
digestive system diseases (7) 7
genotype (7) 7
health aspects (7) 7
hiv-1 - genetics (7) 7
pharmacology & pharmacy (7) 7
ribavirin (7) 7
antiviral agents - therapeutic use (6) 6
cerebrospinal-fluid (6) 6
female (6) 6
genetic aspects (6) 6
hepacivirus - drug effects (6) 6
hepatitis c (6) 6
immunologic diseases. allergy (6) 6
in-vitro (6) 6
inhibitor (6) 6
male (6) 6
middle aged (6) 6
parasitology (6) 6
phylogeny (6) 6
research (6) 6
sofosbuvir (6) 6
abt-450/r-ombitasvir (5) 5
adult (5) 5
antiretroviral therapy (5) 5
central nervous system (5) 5
central nervous system - virology (5) 5
drug therapy, combination (5) 5
genetic variation (5) 5
genotype & phenotype (5) 5
glecaprevir (5) 5
hepatitis c, chronic - drug therapy (5) 5
hiv-1 - physiology (5) 5
human immunodeficiency virus--hiv (5) 5
immunology (5) 5
infectious diseases (5) 5
interferon (5) 5
macrophages - virology (5) 5
patients (5) 5
physiological aspects (5) 5
pibrentasvir (5) 5
prevalence (5) 5
treatment outcome (5) 5
vivo antiviral activity (5) 5
amino acids (4) 4
analysis (4) 4
antiretroviral drugs (4) 4
brain (4) 4
cell line (4) 4
central-nervous-system (4) 4
compensated cirrhosis (4) 4
direct-acting antivirals (4) 4
drug resistance, viral - genetics (4) 4
drug therapy (4) 4
env compartmentalization (4) 4
hek293 cells (4) 4
hiv (4) 4
human immunodeficiency virus (4) 4
human-immunodeficiency-virus (4) 4
immunodeficiency-virus type-1 (4) 4
infection (4) 4
maximum-likelihood (4) 4
open-label (4) 4
phylogenetics (4) 4
plasma (4) 4
replication (4) 4
resistance (4) 4
variants (4) 4
virus replication (4) 4
abt-493 (3) 3
acquired immune deficiency syndrome (3) 3
acquired immune deficiency syndrome--aids (3) 3
aids (3) 3
aids dementia complex - cerebrospinal fluid (3) 3
aids dementia complex - pathology (3) 3
anilides - administration & dosage (3) 3
anilides - therapeutic use (3) 3
antiviral activity (3) 3
antiviral agents - administration & dosage (3) 3
antiviral agents - pharmacology (3) 3
beer (3) 3
biochemistry (3) 3
carbamates - administration & dosage (3) 3
carbamates - therapeutic use (3) 3
care and treatment (3) 3
cd4 antigens - metabolism (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
PLoS Pathogens, ISSN 1553-7366, 10/2011, Volume 7, Issue 10, p. e1002286
Journal Article
JAMA, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, pp. 1223 - 1231
Journal Article
Journal Article
Cytokine, ISSN 1043-4666, 2011, Volume 56, Issue 1, pp. 68 - 69
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 01/2018, Volume 90, Issue 1, pp. 109 - 119
Treatment of HCV genotype (GT) 2‐infected Japanese patients with paritaprevir (NS3/4A inhibitor boosted with ritonavir) and ombitasvir (NS5A inhibitor) without... 
hepatitis C virus | genotype 2 | ombitasvir | paritaprevir | OMBITASVIR/PARITAPREVIR/RITONAVIR | SEQUENCES | SOFOSBUVIR | OPEN-LABEL | RIBAVIRIN | RANDOMIZED PHASE-3 TRIAL | VIVO ANTIVIRAL ACTIVITY | IN-VITRO | VIROLOGY | INFECTED PATIENTS | INHIBITOR | Japan - epidemiology | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - ethnology | Drug Therapy, Combination - adverse effects | Ritonavir - adverse effects | Ribavirin - administration & dosage | Treatment Failure | Ritonavir - therapeutic use | Female | Hepatitis C, Chronic - epidemiology | Hepacivirus - drug effects | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Macrocyclic Compounds - therapeutic use | Polymorphism, Genetic | Drug Resistance, Viral - genetics | Anilides - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Carbamates - adverse effects | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Genetic aspects | Cladistic analysis | Hepatitis C virus | Health aspects | Analysis | Antiretroviral drugs | Ritonavir | Viruses | Amino acids | Infections | Patients | Ribavirin | Disease resistance | Hepatitis | Inhibitors | Failure analysis | Hepatitis C
Journal Article